0000803578 1 2026-05-19 2026-05-19 0000803578 2 2026-05-19 2026-05-19 0000803578 3 2026-05-19 2026-05-19 0000803578 4 2026-05-19 2026-05-19 0000803578 5 2026-05-19 2026-05-19 0000803578 6 2026-05-19 2026-05-19 0000803578 7 2026-05-19 2026-05-19 0000803578 2026-05-19 2026-05-19 iso4217:USD pure shares S-3 EX-FILING FEES 0000803578 N/A N/A S-3 Firefly Neuroscience, Inc. false Equity Common Stock, par value $0.0001 per share true 1213175 1.70 2062397.50 0.0001381 284.82 false Equity Common stock, par value $0.0001 per share, issuable upon exercise of pre-funded warrants true 5620158 1.70 9554268.60 0.0001381 1319.44 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 6833333 1.70 11616666.10 0.0001381 1604.26 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 6833333 1.70 11616666.10 0.0001381 1604.26 false Equity Common Stock, par value $0.0001 per share true 666667 1.70 1133333.90 0.0001381 156.51 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 666667 1.70 1133333.90 0.0001381 156.51 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 666667 1.70 1133333.90 0.0001381 156.51 38250000.00 5282.33 5282.33 Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 1,213,175 shares of Common Stock issued pursuant to the to that certain Securities Purchase Agreement, dated March 8, 2026 (the “March 2026 Securities Purchase Agreement”), by and between the and the Registrant and other parties signatory. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 5,620,158 shares of Common Stock issuable upon exercise of certain pre funded warrants with an initial exercise price of $0.0001 per share pursuant to the March 2026 Securities Purchase Agreement. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 6,833,333 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $1.80 per share pursuant to the March 2026 Securities Purchase Agreement;. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 6,833,333 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $2.50 per share pursuant to the March 2026 Securities Purchase Agreement. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 666,667 shares of Common Stock to be issued pursuant to the to that certain Securities Purchase Agreement, dated May 6, 2026 (the “May 2026 Securities Purchase Agreement”), by and between the and the Registrant and other party signatory thereto (the “May 2026 Investor”). Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 666,667 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $1.80 per share to be issued to the May 2026 Investor pursuant to the May 2026 Securities Purchase Agreement. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on May 15, 2026. Represents up to 666,667 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $2.50 per share to be issued to the May 2026 Investor pursuant to the May 2026 Securities Purchase Agreement. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on May 15, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).